Abbott Laboratories (ABT) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $62.63, down from yesterday’s close by -0.46%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Abbott Laboratories (ABT) currently trades with a market capitalization of $110.27 Billion. That value represents a market adjusting for revenues that have been growing by 16.65 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of $4.97 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.71 on a per share basis this quarter. Perhaps, that suggests something about why 0.81% of the outstanding share supply is held by institutional investors.
No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Abbott Laboratories recorded a 52-week high of $64.60. It is now trading 1.97% off that level. The stock is trading $60.43 its 50-day moving average by -2.2%. The stock carved out a 52-week low down at $47.20.
In recent action, Abbott Laboratories (ABT) has made a move of +3.45% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.57, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.76% with $1.74 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ABT.